Cargando…
P1163: ZANUBRUTINIB PLUS RITUXIMAB AND LENALIDOMIDE (ZR2) FOR RELAPSED AND REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431143/ http://dx.doi.org/10.1097/01.HS9.0000971548.82531.93 |
| _version_ | 1785091131065761792 |
|---|---|
| author | Zhang, Xiyuan Chen, Kang Wang, Hui Deng, Xiuizhi Liu, Guoqiang MA, Junjie Wang, Juan Wang, Xianghua LV, Zhenhui LI, Zengjun Wang, Ling |
| author_facet | Zhang, Xiyuan Chen, Kang Wang, Hui Deng, Xiuizhi Liu, Guoqiang MA, Junjie Wang, Juan Wang, Xianghua LV, Zhenhui LI, Zengjun Wang, Ling |
| author_sort | Zhang, Xiyuan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10431143 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104311432023-08-17 P1163: ZANUBRUTINIB PLUS RITUXIMAB AND LENALIDOMIDE (ZR2) FOR RELAPSED AND REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA Zhang, Xiyuan Chen, Kang Wang, Hui Deng, Xiuizhi Liu, Guoqiang MA, Junjie Wang, Juan Wang, Xianghua LV, Zhenhui LI, Zengjun Wang, Ling Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431143/ http://dx.doi.org/10.1097/01.HS9.0000971548.82531.93 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Zhang, Xiyuan Chen, Kang Wang, Hui Deng, Xiuizhi Liu, Guoqiang MA, Junjie Wang, Juan Wang, Xianghua LV, Zhenhui LI, Zengjun Wang, Ling P1163: ZANUBRUTINIB PLUS RITUXIMAB AND LENALIDOMIDE (ZR2) FOR RELAPSED AND REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA |
| title | P1163: ZANUBRUTINIB PLUS RITUXIMAB AND LENALIDOMIDE (ZR2) FOR RELAPSED AND REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA |
| title_full | P1163: ZANUBRUTINIB PLUS RITUXIMAB AND LENALIDOMIDE (ZR2) FOR RELAPSED AND REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA |
| title_fullStr | P1163: ZANUBRUTINIB PLUS RITUXIMAB AND LENALIDOMIDE (ZR2) FOR RELAPSED AND REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA |
| title_full_unstemmed | P1163: ZANUBRUTINIB PLUS RITUXIMAB AND LENALIDOMIDE (ZR2) FOR RELAPSED AND REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA |
| title_short | P1163: ZANUBRUTINIB PLUS RITUXIMAB AND LENALIDOMIDE (ZR2) FOR RELAPSED AND REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA |
| title_sort | p1163: zanubrutinib plus rituximab and lenalidomide (zr2) for relapsed and refractory diffuse large b cell lymphoma |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431143/ http://dx.doi.org/10.1097/01.HS9.0000971548.82531.93 |
| work_keys_str_mv | AT zhangxiyuan p1163zanubrutinibplusrituximabandlenalidomidezr2forrelapsedandrefractorydiffuselargebcelllymphoma AT chenkang p1163zanubrutinibplusrituximabandlenalidomidezr2forrelapsedandrefractorydiffuselargebcelllymphoma AT wanghui p1163zanubrutinibplusrituximabandlenalidomidezr2forrelapsedandrefractorydiffuselargebcelllymphoma AT dengxiuizhi p1163zanubrutinibplusrituximabandlenalidomidezr2forrelapsedandrefractorydiffuselargebcelllymphoma AT liuguoqiang p1163zanubrutinibplusrituximabandlenalidomidezr2forrelapsedandrefractorydiffuselargebcelllymphoma AT majunjie p1163zanubrutinibplusrituximabandlenalidomidezr2forrelapsedandrefractorydiffuselargebcelllymphoma AT wangjuan p1163zanubrutinibplusrituximabandlenalidomidezr2forrelapsedandrefractorydiffuselargebcelllymphoma AT wangxianghua p1163zanubrutinibplusrituximabandlenalidomidezr2forrelapsedandrefractorydiffuselargebcelllymphoma AT lvzhenhui p1163zanubrutinibplusrituximabandlenalidomidezr2forrelapsedandrefractorydiffuselargebcelllymphoma AT lizengjun p1163zanubrutinibplusrituximabandlenalidomidezr2forrelapsedandrefractorydiffuselargebcelllymphoma AT wangling p1163zanubrutinibplusrituximabandlenalidomidezr2forrelapsedandrefractorydiffuselargebcelllymphoma |